Historical record - last NADAC effective date: 6/19/2024
Product Information
ATORVASTATIN 20 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0384 per EA under NDC 69097094505. Its NADAC has been published 338 times since Jan 10, 2018.
FDA first approved this application on May 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Cipla USA Inc.NDC
69097094505
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205519FDA Approved
5/19/2016
TE Code
AB
On Market Since
11/16/2017
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 20 MG TABLET has been published 338 times since Jan 10, 2018, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0384 per EA |
|---|---|
| All-time high | $0.0889 (Jul 10, 2019) |
| All-time low | $0.0338 (May 22, 2024) |
| Median price | $0.0574 |
| Average price | $0.0603 |
| Largest weekly change | +24.2% (May 22, 2019) |
| Weeks tracked | 338 |
| Tracking since | Jan 10, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-5.8%
5Y
-30.6%
All
-51.8%
Last surveyed Jun 26, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Cipla USA Inc., is $0.0384 per EA (NDC 69097094505), effective Jun 26, 2024.
How has the price of ATORVASTATIN 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 51.8%. It has been tracked across 338 weekly CMS publications since Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?
Since Jan 10, 2018, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0338 (May 22, 2024) to a high of $0.0889 (Jul 10, 2019), with a median of $0.0574 per EA.
Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 20 MG TABLET, is $0.0276 per EA — about 28% below ATORVASTATIN 20 MG TABLET.
Who manufactures ATORVASTATIN 20 MG TABLET?
ATORVASTATIN 20 MG TABLET (NDC 69097094505) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.